Clinical Trials Logo

Refractive Errors clinical trials

View clinical trials related to Refractive Errors.

Filter by:
  • Completed  
  • Page 1 ·  Next »

NCT ID: NCT06335212 Completed - Myopia Clinical Trials

Peripheral Defocus Profile of Multifocal Minus Contact Lenses

Start date: June 1, 2019
Phase:
Study type: Observational

Purpose: Numerous studies have proven that emmetropization in young animals including humans is regulated by visual input. It has long been hypothesized that peripheral myopic defocus may act as a stop signal to reduce myopia progression and axial elongation. As such, multifocal soft contact lenses (MFCLs) have been utilized for myopia control in school-aged children, with variable efficacies. One potential explanation is that the actual peripheral myopic defocus an eye experiences during MFCL wear may not be identical to the Add power and not sufficient to reduce myopia progression. Our study investigated and compared the peripheral power profiles of myopic eyes when they were uncorrected and wore single vision contact lenses (SVCLs) and MFCLs of different Add powers. Methods: Subjects with -1.00 D to -10.00 D of myopia (SE, determined with manifest refraction) were custom fit with both single vision (SV) and MFCLs (+2.00 and +4.00 D Add; provided by Specialeyes) in both eyes. These Specialeyes MFCLs had an aspheric design with a standard total optical zone of 8.0mm. Cycloplegic central autorefraction was conducted with both Grand Seiko WAM-5500 open-field auto-refractor (Grand Seiko Co Ltd) and OPD OPD-Scan III Wavefront Aberrometer (Marco) on the subjects in the following conditions: (1) no CLs, (2) SVCLs, (3) MFCLs (+2.00D Add), and (4) MFCLs (+4.00D Add). Relative peripheral power profiles were measured using the OPD under the same 4 conditions after cycloplegia. Data in the right eye was used for analysis.

NCT ID: NCT06209476 Completed - Refractive Error Clinical Trials

Clinical Investigation on Assessing the Repeatability and Reproducibility of Central and Peripheral Refractive Error

Start date: January 16, 2024
Phase:
Study type: Observational

This is a unilateral, non-interventional study. Each subject will be unilaterally measured with the WAM-5500 autorefractor by 3 testers. All measurements will be made on the right eye only.

NCT ID: NCT06165627 Completed - Astigmatism Clinical Trials

Comparison of Clinical Performance of Two Monthly Replacement Toric Soft Contact Lenses

Start date: January 23, 2024
Phase: N/A
Study type: Interventional

The purpose of this study is to assess the clinical performance of TOTAL30 for Astigmatism (T30fA) soft contact lenses with Biofinity Toric soft contact lenses.

NCT ID: NCT06148428 Completed - Refractive Errors Clinical Trials

Anxiety-related Fixation Instability During LASIK

Start date: August 15, 2018
Phase:
Study type: Observational

Anxiety is common among patients undergoing eye surgery, which is typically performed under topical anesthesia while the patient is awake. This can be an unsettling experience for patients, who may worry about being able to keep their eyes still during surgery, cooperate with the surgical team, and remain immobile in an unfamiliar environment. Patients may also experience anxiety due to concerns about surgical pain, possible complications, and the uncertainty of the outcome of the surgery. In this study, the investigators aimed to investigate the correlation between the severity of anxiety symptoms during LASIK, and fixation instability during photo-ablation as plotted by the eye tracker.

NCT ID: NCT06098937 Completed - Clinical trials for Refractive Ametropia

Kalifilcon A Toric Compared to Commercially Available Lenses

Start date: September 5, 2023
Phase: N/A
Study type: Interventional

Approximately 30 soft toric contact lens adapted subjects will be enrolled in this feasibility, bilateral, randomized, double masked (subject and investigator masked), repeated measures insertion study. All subjects will be seen for a Screening/Dispensing Visit at which informed consent will be obtained and eligibility will be assessed. If subjects satisfy all eligibility criteria and none of the exclusion criteria, subjects will have study lenses inserted in random, successive order according to unique randomization schedules that will be provided to each Investigator.

NCT ID: NCT06053736 Completed - Clinical trials for Refractive Ametropia

1-Week Dispensing Evaluation of REVIVEā„¢ Toric Soft Contact Lenses

Start date: October 4, 2023
Phase: N/A
Study type: Interventional

Experienced soft contact lens wearing subjects will be enrolled in this 1-week, post-market, bilateral, repeated measures, dispensing study. All subjects will be seen for a Screening/Dispensing Visit at which informed consent will be obtained and eligibility will be assessed. If subjects satisfy all eligibility criteria and none of the exclusion criteria, subjects will be fit and dispensed study lenses. If unsuccessful in the dispensed lenses, additional lenses may be trialed. Once vision and lens fit are determined to be acceptable, eligible subjects will wear study lenses in both eyes for at least 8 hours per day (with the exception of the follow-up visits where the lenses should be worn for a minimum of 2 hours), for approximately 1 week (7 days +/-3 days). Measurements will be taken at the insertion visit and at the 7-day follow-up visit.

NCT ID: NCT06044948 Completed - Refractive Errors Clinical Trials

Clinical Assessment of a Daily Disposable Soft Silicone Hydrogel Contact Lens

Start date: October 13, 2023
Phase: N/A
Study type: Interventional

The purpose of this study is to assess the clinical performance of DAILIES TOTAL1® spherical soft contact lenses over approximately 1 week of daily wear.

NCT ID: NCT05959200 Completed - Myopia Clinical Trials

Clinical Performance Evaluation of Two Frequent Replacement Silicone Hydrogel Toric Contact Lenses

Start date: August 14, 2023
Phase: N/A
Study type: Interventional

The primary objective of this study is to evaluate the axis orientation of LID226397 toric contact lenses.

NCT ID: NCT05957458 Completed - Myopia Clinical Trials

Myopia Control With Three Lever Irradiance of PBM Therapy in Children and Adults

MCPT
Start date: January 1, 2021
Phase: N/A
Study type: Interventional

Photobiomodulation therapy, that is, Low-level red-light technology provides a new and innovative myopia control approach. This strategy enables relatively high energies of light to be delivered at much shorter durations of exposure to induce the myopia control effect. The efficacy of the low-level red-light technology has been proven in a Chinese populationb for the recent 3 years with evidence based papers and amazing results. However, there's not yet evidence to demonstrate the relationship between the dose response effect of photobiomodulation therapy on myopia control at the different age lever.

NCT ID: NCT05936489 Completed - Presbyopia Clinical Trials

Plasma Pharmacokinetics and Safety of LNZ101 and LNZ100 Ophthalmic Solutions in Healthy Adult Subjects With Presbyopia

Start date: July 6, 2023
Phase: Phase 1
Study type: Interventional

This is a single-center, open-label, randomized study to assess the plasma pharmacokinetic profile of LNZ101 and LNZ100.